| Literature DB >> 29375519 |
Kyle L Asfahl1, Martin Schuster1.
Abstract
In the opportunistic pathogen Pseudomonas aeruginosa, quorum sensing (QS) via acyl-homoserine lactone (AHL) signals coordinates virulence gene expression. AHL signals must reach a critical threshold before enough is bound by cognate regulators LasR and RhlR to drive transcription of target genes. In addition, three anti-activator proteins, QteE, QscR, and QslA, sequester QS regulators to increase the threshold for induction and delay expression of QS target genes. It remains unclear how multiple anti-activators work together to achieve the quorum threshold. Here, we employed a combination of mutational, kinetic, phenotypic, and transcriptomic analysis to examine regulatory effects and interactions of the three distinct anti-activators. We observed combinatorial, additive effects on QS gene expression. As measured by reporter gene fusion, individual deletion of each anti-activator gene increased lasB expression and QS-controlled virulence factor production. Deletion of qslA in combination with the deletion of any other anti-activator gene resulted in the greatest increase and earliest activation of lasB gene expression. Western analysis revealed that relative increases in soluble LasR in anti-activator mutants correlate with increased lasB expression and QS-controlled virulence factor production. RNA-seq of the previously uncharacterized QslA and QteE regulons revealed overlapping, yet distinct groups of differentially expressed genes. Simultaneous inactivation of qteE and qslA had the largest effect on gene expression with 999 genes induced and 798 genes repressed in the double mutant vs. wild-type. We found that LasR and RhlR-activated QS genes formed a subset of the genes induced in the qteE, qslA, and double mutant. The activation of almost all of these QS genes was advanced from stationary phase to log phase in the qteE qslA double mutant. Taken together, our results identify additive effects of anti-activation on QS gene expression, likely via LasR and RhlR, but do not rule out QS-independent effects.Entities:
Keywords: Pseudomonas aeruginosa; RNA-seq/transcriptomics; acyl-homoserine lactone; anti-activator; gene expression; quorum sensing
Year: 2018 PMID: 29375519 PMCID: PMC5767178 DOI: 10.3389/fmicb.2017.02654
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Anti-activators in the P. aeruginosa AHL-QS circuitry. QS receptor-regulators (white labels) LasR (light blue) and RhlR (dark blue) homodimerize upon cognate signal binding of 3OC12-HSL (Las, light blue star) or C4-HSL (Rhl, dark blue star), leading to activation of overlapping LasR and RhlR regulons, respectively (Venn diagram). Anti-activators (black labels) QscR (red), QteE (green), and QslA (orange) all interact with LasR and RhlR to suppress QS activation. QteE likely forms heteromultimers with both LasR and RhlR separately, leading to degradation of each regulator. The exact stoichiometry of QteE-R-protein complexes is not known. QslA is only known to form heterotrimers with LasR in a 2:1 ratio, but the overall fate of this complex beyond suppression of QS is not entirely clear. QslA can also dissociate and then bind previously formed LasR homodimers (dashed line). QscR appears to form heterodimers with both LasR and RhlR, but also acts as an orphan receptor-regulator that can homodimerize upon binding of 3OC12-HSL and regulate its own overlapping QS regulon (Venn diagram). Venn diagram lobes are not scaled to reflect relative size of each regulon.
Bacterial strains and plasmids.
| PAO1 | Wild-type, PAO1 UW library strain (originally from B. Iglewski, Rochester) | Jacobs et al., |
| PAO Δ | PAO1 derivative; markerless | Siehnel et al., |
| PAOR3 | PAO1 derivative; | Chugani et al., |
| PAO Δ | PAO1 derivative; Δ | This study |
| PAO Δ | PAO1 Δ | This study |
| PAO | PAOR3 derivative; marked double-null mutant which harbors both Δ | This study |
| PAO Δ | PAO1 Δ | This study |
| PAO Δ | PAO1 Δ | This study |
| DA6 | PAO1 derivative; Δ | Siehnel et al., |
| DH5α | F−Φ80 | Invitrogen |
| SM10 | Simon et al., | |
| pEX18Gm | Conjugative suicide plasmid; GmR | Hoang et al., |
| pEX18Gm.Δ | pEX18Gm with Δ | This study |
| pProbeAT | Broad-host-range vector with a promoterless | Miller et al., |
| pRG13 | 240 bp | Gupta and Schuster, |
Figure 2Effects of anti-activator gene deletion on P-gfp expression kinetics. (A) Growth of strains in CAA medium. (B) P-gfp expression levels vs. time. Expression levels are normalized to OD600. Inset has reduced x- and y-axes to emphasize expression timing. (C) P-gfp expression rates vs. time, showing time derivatives of OD-normalized expression levels. Inset has a reduced y-axis to emphasize expression rate peaks in the wild-type. (D) OD-normalized P-gfp expression levels vs. cell density. Inset has a reduced y-axis to emphasize the wild-type expression profile. In all panels, values represent means of three biological replicates. Error bars indicate s.e.m. (n = 3).
Figure 3Effects of anti-activator gene deletion on QS phenotypes. (A) Elastase activity. (B) Pyocyanin production. Each assay was performed separately after 18 h of growth in CAA medium (stationary phase, OD600 = 1.9–2.3). In both panels, values represent means of three biological replicates, and y-axes are split to allow visualization of the lowest values. Error bars indicate s.e.m. (n = 3). Bars are grouped for clarity. Significant differences (*) in selected individual pairwise comparisons were determined using a two-tailed T-test (α = 0.05). (C) LasR Western analysis. Equal amounts of protein (5 μg) were added to each well. Log phase and early stationary phase blot bands are from separate gels, and therefore may not be directly comparable. Blots pictured are representative of replicate experiments. Relative LasR levels within each growth phase were quantified by densitometric analysis and are presented as ratios relative to wild-type.
Differentially expressed genes.
| WT vs. | 1 | – | 1 | 79 | 59 | 138 | 79 | 59 | 138 |
| 52 | 2 | 54 | 298 | 101 | 399 | 312 | 103 | 415 | |
| 82 | 8 | 90 | 477 | 265 | 742 | 500 | 270 | 770 | |
| 214 | 52 | 266 | 934 | 757 | 1691 | 999 | 798 | 1797 | |
All DE genes values were produced by adding Log and Early stationary gene lists and removing duplicates. DE, differentially expressed; WT, wild-type.
Figure 4Comparison of differentially expressed (DE) genes among anti-activator mutants. (A) DE genes in log phase. (B) DE genes in early stationary phase. DE genes were determined in DESeq2 using three biological replicates (false discovery rate α = 0.05, n = 3). Venn diagram variables are roughly scaled to reflect quantities in order to visualize nesting. (C) Absolute expression. Expression levels were calculated as the Z-score for individual samples among rows of both log and early stationary phase regularized log (rlog) values generated in DESeq2 using three biological replicates (n = 3). Rows selected represent all DE genes from anti-activator mutant comparisons (1803 genes total) and are clustered by average linkage using the Pearson correlation. (D) Principal component analysis (PCA) of absolute expression results depicted in (C). Unit variance scaling is applied to rows; singular value decomposition with imputation is used to calculate principal components. x and y axis show principal component 1 and principal component 2 that explain 68 and 18% of the total variance, respectively (n = 8 data points). Open symbols, log phase; filled symbols, early stationary phase. Black, wild-type; green, qteE; orange, qslA; purple, qteE qslA.
Figure 5A QS-controlled regulon. (A) Histogram of genes differentially expressed in a wild-type vs. lasR rhlR mutant comparison from early stationary phase cultures grown in CAA medium. Differentially expressed (DE) genes activated (black bars) and repressed (gray bars) in the comparison were determined in DESeq2 using three biological replicates (false discovery rate α = 0.05, n = 3). FC, fold-change. Values were binned to span defined intervals of 0.5 × log2-FC, and bins were positioned over interval centers in the histogram. (B) Comparison of QS regulons among previous microarray results (Hentzer et al., 2003; Schuster et al., 2003; Wagner et al., 2003) and the present study. Venn diagrams are not scaled to gene number. (C) Comparison of lasB (PA3724) fold-change in the RNA-seq experiment. “QS” fold-change represents results from the wild-type vs. lasR rhlR comparison; all others represent results of individual comparisons with each strain vs. the wild-type.
Quorum-activated genes.
| PA0026 | phospholipase C, PlcB | 2.5 | NC | 2.3 | 2.1 | |
| PA0027 | hypothetical protein | 2.2 | 1.8 | |||
| PA0052 | hypothetical protein | 2.3 | 4.6 | 9.6 | 14.9 | |
| PA0143 | purine nucleosidase Nuh | 1.9 | ||||
| PA0178 | probable two-component sensor | 2.4 | NC | NC | 1.7 | |
| PA0524 | nitric-oxide reductase subunit B | 7.8 | NC | NC | −10.7 | |
| PA0572 | hypothetical protein | 3.6 | 2.9 | |||
| PA1130 | rhamnosyltransferase 2 | 4.3 | 5.4 | 5.6 | ||
| PA1131 | probable major facilitator superfamily (MFS) transporter | 11.0 | 6.1 | 5.3 | ||
| PA1246 | alkaline protease secretion protein AprD | 3.3 | NC | NC | ||
| PA1248 | Alkaline protease secretion outer membrane protein AprF precursor | 2.6 | NC | NC | ||
| PA1249 | alkaline metalloproteinase precursor | 3.6 | 3.6 | 4.5 | 7.0 | |
| PA1250 | alkaline proteinase inhibitor AprI | 3.7 | ||||
| PA1251 | probable chemotaxis transducer | 3.3 | ||||
| PA1430 | transcriptional regulator LasR | 1.7 | ||||
| PA1431 | regulatory protein RsaL | 6.1 | 4.1 | |||
| PA1432 | autoinducer synthesis protein LasI | 28.0 | − | −1.6 | ||
| PA1433 | conserved hypothetical protein | 1.6 | NC | |||
| PA1656 | HsiA2 | 3.5 | ||||
| PA1663 | Sfa2 | 2.3 | 9.2 | 4.5 | ||
| PA1668 | DotU2 | 1.8 | 8.6 | |||
| PA1784 | hypothetical protein | 2.3 | 3.5 | 7.2 | 13.4 | |
| PA1869 | probable acyl carrier protein | 3.5 | ||||
| PA1871 | LasA protease precursor | 3.4 | 22.9 | 22.9 | 36.6 | |
| PA1893 | hypothetical protein | 2.5 | NC | |||
| PA1894 | hypothetical protein | 3.9 | ||||
| PA1895 | hypothetical protein | 2.3 | NC | |||
| PA1896 | hypothetical protein | 2.4 | NC | |||
| PA1897 | hypothetical protein | 2.5 | ||||
| PA2076 | probable transcriptional regulator | 1.8 | ||||
| PA2080 | kynureninase KynU | 1.7 | ||||
| PA2081 | kynurenine formamidase, KynB | 2.5 | ||||
| PA2193 | hydrogen cyanide synthase HcnA | 4.9 | 12.1 | 19.3 | ||
| PA2194 | hydrogen cyanide synthase HcnB | 5.4 | 12.7 | |||
| PA2195 | hydrogen cyanide synthase HcnC | 3.8 | 13.8 | 20.8 | ||
| PA2301 | hypothetical protein | 4.0 | 2.7 | 3.0 | 3.5 | |
| PA2302 | AmbE | 18.9 | ||||
| PA2303 | AmbD | 25.6 | ||||
| PA2304 | AmbC | 13.3 | ||||
| PA2305 | AmbB | 12.2 | ||||
| PA2423 | hypothetical protein | 3.1 | ||||
| PA2587 | probable FAD-dependent monooxygenase | 8.1 | ||||
| PA2588 | probable transcriptional regulator | 1.9 | ||||
| PA2591 | VqsR | 7.1 | ||||
| PA2592 | probable periplasmic spermidine/putrescine-binding protein ( | 3.7 | ||||
| PA2607 | conserved hypothetical protein | 1.6 | NC | NC | NC | |
| PA2608 | conserved hypothetical protein ( | 1.5 | NC | NC | NC | |
| PA2939 | probable aminopeptidase ( | 2.7 | 4.1 | 9.1 | 11.5 | |
| PA2949 | probable lipase | 1.4 | NC | NC | NC | |
| PA3326 | ClpP2 | 2.5 | 7.2 | 7.3 | ||
| PA3327 | probable non-ribosomal peptide synthetase | 3.3 | 16.1 | 8.1 | ||
| PA3328 | probable FAD-dependent monooxygenase | 4.5 | 21.9 | 12.4 | ||
| PA3329 | hypothetical protein | 3.6 | 25.1 | 13.9 | ||
| PA3330 | probable short chain dehydrogenase | 4.1 | 18.3 | 11.1 | ||
| PA3331 | cytochrome P450 | 3.5 | 20.3 | 11.6 | ||
| PA3332 | conserved hypothetical protein | 3.3 | 23.4 | 13.4 | ||
| PA3333 | 3-oxoacyl-[acyl-carrier-protein] synthase III | 4.4 | 22.9 | 11.9 | ||
| PA3336 | probable major facilitator superfamily (MFS) transporter | 2.6 | 18.5 | 10.0 | ||
| PA3346 | two-component response regulator | 1.7 | NC | 2.0 | ||
| PA3391 | regulatory protein NosR | 8.6 | NC | NC | −21.7 | |
| PA3392 | nitrous-oxide reductase precursor | 10.7 | NC | NC | −13.5 | |
| PA3476 | autoinducer synthesis protein RhlI | 10.5 | ||||
| PA3477 | transcriptional regulator RhlR | 7.2 | ||||
| PA3479 | rhamnosyltransferase chain A | 2.2 | 36.7 | 24.3 | ||
| PA3535 | probable serine protease ( | 2.8 | ||||
| PA3615 | hypothetical protein | 1.6 | NC | NC | −1.5 | |
| PA3904 | hypothetical protein | 15.0 | ||||
| PA3905 | hypothetical protein | 10.5 | ||||
| PA3906 | hypothetical protein | 17.4 | ||||
| PA3907 | hypothetical protein | 8.4 | ||||
| PA3908 | hypothetical protein | 5.8 | ||||
| PA4117 | bacterial phytochrome, BphP | 1.8 | ||||
| PA4190 | probable FAD-dependent monooxygenase | 2.5 | ||||
| PA4594 | probable ATP-binding component of ABC transporter | 1.9 | NC | 2.1 | 2.6 | |
| PA4677 | hypothetical protein | 1.8 | 3.7 | |||
| PA4778 | CueR ( | 1.8 | ||||
| PA4869 | hypothetical protein | 1.7 | ||||
| PA4955 | hypothetical protein | 1.6 | NC | NC | NC | |
| PA5255 | Alginate regulatory protein AlgQ ( | 1.5 | NC | NC | NC | |
Locus tags, gene names, and gene annotations from the Pseudomonas Genome Database (.
QS represents the WT vs. lasR rhlR comparison, while all anti-activator mutant comparisons are vs. the wild-type. BOLD denotes genes of the quorum-activated regulon in early stationary phase also differentially expressed in log phase. Negative values indicate repression, positive values indicate activation. NC, no change.
This fold change estimate represents native expression of lasR in the wild-type vs. no expression in the lasR rhlR mutant.
Quorum-repressed genes.
| PA0045 | hypothetical protein | −2.2 | NC | −2.9 | −3.3 | |
| PA0047 | hypothetical protein | −2.3 | NC | −1.9 | −2.3 | |
| PA0592 | rRNA (adenine-N6,N6)-dimethyltransferase | −1.6 | NC | NC | −1.4 | |
| PA0944 | phosphoribosylaminoimidazole synthetase | −1.8 | NC | NC | NC | |
| PA1302 | probable heme utilization protein precursor ( | −2.1 | NC | NC | NC | |
| PA1303 | signal peptidase | −2.4 | NC | NC | NC | |
| PA1542 | hypothetical protein | −1.8 | NC | 1.7 | 1.9 | |
| PA1580 | citrate synthase ( | −1.6 | NC | NC | NC | |
| PA1595 | hypothetical protein | −1.9 | NC | NC | NC | |
| PA1757 | homoserine kinase | −2.0 | NC | NC | NC | |
| PA1791 | hypothetical protein | −1.9 | NC | − | −3.1 | |
| PA2583 | probable sensor/response regulator hybrid | −1.7 | NC | NC | NC | |
| PA2665 | Transcriptional activator of P. aeruginosa flavohemoglobin, FhpR ( | −1.7 | NC | NC | NC | |
| PA2770 | hypothetical protein | −1.7 | NC | NC | 2.3 | |
| PA2780 | bacterial swarming regulator BswR | −1.5 | ||||
| PA2930 | probable transcriptional regulator | −2.4 | NC | NC | NC | |
| PA2950 | proton motive force protein, PMF | −1.6 | NC | NC | NC | |
| PA2964 | 4-amino-4-deoxychorismate lyase | −1.5 | NC | NC | NC | |
| PA2970 | 50S ribosomal protein L32 | −2.1 | NC | NC | NC | |
| PA2998 | Na+-translocating NADH:ubiquinone oxidoreductase subunit Nrq2 | −1.8 | NC | NC | NC | |
| PA3079 | hypothetical protein | −1.9 | NC | NC | NC | |
| PA3111 | folylpolyglutamate synthetase | −1.6 | NC | NC | NC | |
| PA3174 | probable transcriptional regulator | −1.9 | −2.3 | −2.7 | − | |
| PA3268 | probable TonB–dependent receptor | −3.4 | NC | NC | ||
| PA3284 | hypothetical protein | −3.3 | −5.5 | −7.4 | −8.8 | |
| PA3362 | hypothetical protein ( | −2.3 | 8.0 | 12.4 | 7.3 | |
| PA3473 | hypothetical protein | −1.7 | NC | NC | NC | |
| PA3609 | polyamine transport protein PotC | −2.0 | NC | NC | NC | |
| PA3820 | secretion protein SecF | −2.5 | NC | NC | NC | |
| PA3823 | queuine tRNA-ribosyltransferase | −1.8 | NC | NC | −1.8 | |
| PA3827 | Lipopolysaccharide export system permease protein LptG ( | −1.5 | NC | NC | NC | |
| PA3979 | hypothetical protein | −1.6 | NC | NC | NC | |
| PA4045 | conserved hypothetical protein ( | −1.7 | NC | NC | NC | |
| PA4046 | hypothetical protein | −1.5 | NC | NC | NC | |
| PA4375 | Resistance-Nodulation-Cell Division (RND) multidrug efflux transporter MexW | −1.7 | NC | NC | NC | |
| PA4479 | rod shape-determining protein MreD | −2.8 | NC | NC | NC | |
| PA4519 | ornithine decarboxylase | −1.8 | 1.9 | 2 | 3.2 | |
| PA4562 | conserved hypothetical protein ( | −1.7 | NC | NC | NC | |
| PA4569 | octaprenyl-diphosphate synthase ( | −1.8 | NC | NC | −1.9 | |
| PA4628 | lysine-specific permease | −1.7 | NC | NC | NC | |
| PA4630 | hypothetical protein | −2.0 | −1.6 | −2.6 | −2.5 | |
| PA4672 | peptidyl-tRNA hydrolase ( | −2.1 | NC | NC | NC | |
| PA4757 | conserved hypothetical protein ( | −1.5 | NC | NC | −1.4 | |
| PA4840 | conserved hypothetical protein ( | −1.6 | NC | NC | NC | |
| PA5072 | probable chemotaxis transducer | −1.5 | NC | NC | NC | |
| PA5081 | hypothetical protein | −2.0 | −1.8 | NC | −1.5 | |
| PA5117 | regulatory protein TypA ( | −1.7 | NC | NC | NC | |
| PA5139 | hypothetical protein | −2.2 | NC | NC | −3.3 | |
| PA5156 | hypothetical protein | −1.8 | NC | NC | NC | |
| PA5167 | DctP | −3.9 | NC | NC | NC | |
| PA5168 | DctQ | −4.3 | NC | NC | NC | |
| PA5169 | DctM | −4.9 | NC | NC | NC | |
| PA5194 | hypothetical protein | −1.7 | NC | NC | NC | |
| PA5250 | conserved hypothetical protein | −1.7 | NC | NC | NC | |
| PA5251 | hypothetical protein | −1.7 | NC | NC | NC | |
| PA5320 | Phosphopantothenoylcysteine synthase/(R)-4′-phospho-N-pantothenoylcysteine decarboxylase ( | −1.4 | NC | NC | −1.3 | |
| PA5361 | two-component sensor PhoR | −1.6 | NC | NC | NC | |
| PA5492 | conserved hypothetical protein ( | −1.9 | NC | NC | NC | |
| PA5560 | ATP synthase A chain ( | −1.8 | NC | NC | −2.4 | |
Locus tags, gene names, and gene annotations from the Pseudomonas Genome Database (.
QS represents the WT vs. lasR rhlR comparison, while all anti-activator mutant comparisons are vs. the wild-type. BOLD denotes genes of the quorum-repressed regulon in early stationary phase also differentially expressed in log phase. Negative values indicate repression, positive values indicate activation. NC, no change.
Figure 6Overlap of induced genes in QS and anti-activator regulons. (A) Log phase anti-activator regulons and early stationary phase QS regulon. (B) Early stationary phase anti-activator regulons and early stationary phase QS regulon. For both panels: Differentially expressed (DE) genes were determined in DESeq2 (see Materials and Methods) using three biological replicates (false discovery rate α = 0.05, n = 3). Values represent only induced genes, and Venn diagrams are not scaled to gene number.
Figure 7Absolute expression of the QS regulon. Absolute expression was calculated as the Z-score for individual samples among rows of both log and early stationary phase regularized log (rlog) values generated in DESeq2 (see Materials and Methods) using three biological replicates (n = 3). Rows selected represent only induced genes in the QS regulon and are ordered by locus tag (middle column) for reference. WT, wild-type.
Figure 8Absolute expression of genes coding for QS machinery and anti-activators in the wild-type. Absolute expression is presented as regularized log (rlog) values generated in DESeq2 using three biological replicates (n = 3). Absolute gene expression in log phase (light bars) and early stationary phase (dark bars) are grouped by gene as QS machinery (green bars) or anti-activators (red bars). Bars represent means + s.e.m. (n = 3). *indicates significantly higher expression in early stationary phase than log phase, two-tailed T-test (α = 0.05).
Figure 9Broader context and functional relationship between quorum and anti-activator regulons. (A) Comparison of an extended QS regulon with genes induced in the qteE qslA anti-activator mutant in early stationary phase. The extended QS regulon contains all QS-induced genes identified in the current study and in previously published QS studies (Hentzer et al., 2003; Schuster et al., 2003; Wagner et al., 2003). Venn diagram is not scaled to gene number. (B) Functional classification of induced genes. Functional classes and annotations were retrieved from the Pseudomonas Genome Database. Bars represent percent of each functional class represented in induced gene lists, scaled to the size of the wild-type percentage of all genes (1.4%). Induced gene lists for each sample were assembled from differentially expressed (DE) genes in early stationary phase as determined in DESeq2 using three biological replicates (false discovery rate α = 0.05, n = 3).